Comparing cancer drug approval systems in the United States and Japan
Health Sci Rep
.
2023 May 10;6(5):e1265.
doi: 10.1002/hsr2.1265.
eCollection 2023 May.
Authors
Yudai Kaneda
1
,
Hideki Maeda
2
,
Akihiko Ozaki
3
,
Yuka Higuchi
4
,
Tetsuya Tanimoto
5
Affiliations
1
School of Medicine Hokkaido University Hokkaido Japan.
2
Department of Regulatory Science Meiji Pharmaceutical University Tokyo Japan.
3
Department of Breast and Thyroid Surgery Jyoban Hospital of Tokiwa Foundation Fukushima Japan.
4
School of Medicine Kyushu University Fukuoka Japan.
5
Department of Internal Medicine Jyoban Hospital of Tokiwa Foundation Fukushima Japan.
PMID:
37181668
PMCID:
PMC10170880
DOI:
10.1002/hsr2.1265
No abstract available